Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,315,000 | 480,000 | -1,303,000 | -2,556,000 | -4,170,000 |
| Depreciation Amortization | 696,000 | 2,767,000 | 2,074,000 | 1,384,000 | 690,000 |
| Income taxes - deferred | -199,000 | -1,844,000 | -1,465,000 | -889,000 | -723,000 |
| Accounts receivable | 79,000 | 139,000 | 67,000 | -95,000 | -66,000 |
| Accounts payable and accrued liabilities | -105,000 | 290,000 | 348,000 | -11,000 | 72,000 |
| Other Working Capital | -780,000 | 3,783,000 | 3,311,000 | 2,164,000 | 3,672,000 |
| Other Operating Activity | 751,000 | 5,213,000 | 4,821,000 | 3,547,000 | 2,744,000 |
| Operating Cash Flow | $1,757,000 | $10,828,000 | $7,853,000 | $3,544,000 | $2,219,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 2,348,000 | 2,348,000 | 2,348,000 | 2,348,000 |
| PPE Investments | -104,000 | -523,000 | -376,000 | -235,000 | -105,000 |
| Net Acquisitions | -273,000 | -4,840,000 | -4,765,000 | -4,195,000 | -4,043,000 |
| Purchase Of Investment | -16,000 | -492,000 | -453,000 | -444,000 | -410,000 |
| Other Investing Activity | -22,000 | 58,000 | 22,000 | 12,000 | 3,000 |
| Investing Cash Flow | $-415,000 | $-3,449,000 | $-3,224,000 | $-2,514,000 | $-2,207,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,464,000 | N/A | N/A | N/A |
| Debt Repayment | -1,762,000 | -1,970,000 | -1,963,000 | -1,851,000 | 0 |
| Common Stock Issued | 252,000 | 422,000 | 249,000 | 151,000 | 146,000 |
| Common Stock Repurchased | -730,000 | -1,150,000 | -800,000 | -500,000 | -400,000 |
| Dividend Paid | -1,010,000 | -3,918,000 | -2,945,000 | -1,962,000 | -990,000 |
| Other Financing Activity | -176,000 | -281,000 | -234,000 | -152,000 | -117,000 |
| Financing Cash Flow | $-3,426,000 | $-3,433,000 | $-5,693,000 | $-4,314,000 | $-1,361,000 |
| Exchange Rate Effect | 19,000 | -40,000 | 15,000 | -29,000 | -18,000 |
| Beginning Cash Position | 9,991,000 | 6,085,000 | 6,085,000 | 6,085,000 | 6,085,000 |
| End Cash Position | 7,926,000 | 9,991,000 | 5,037,000 | 2,772,000 | 4,718,000 |
| Net Cash Flow | $-2,065,000 | $3,906,000 | $-1,049,000 | $-3,313,000 | $-1,367,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,757,000 | 10,828,000 | 7,853,000 | 3,544,000 | 2,219,000 |
| Capital Expenditure | -104,000 | -523,000 | -376,000 | -235,000 | -105,000 |
| Free Cash Flow | 1,653,000 | 10,305,000 | 7,477,000 | 3,309,000 | 2,114,000 |